About Jennifer Ahlstrom
Articles by Jennifer Ahlstrom
ASCO 2020: Are Myeloma Patients Getting the Right Vaccinations?May 26, 2020
Karyopharm Donates Free Masks for Multiple Myeloma and Other PatientsMay 14, 2020
Blood Based MRD Testing Advances in Multiple Myeloma During COVID-19May 13, 2020
Who is Really at Risk for Severe COVID-19 Outcomes? Common Risk Factors Mean it Could be You.Apr 30, 2020
A New Imaging Method in Multiple Myeloma Using Daratumumab as a PET/CT TracerApr 29, 2020
Protecting the Most Vulnerable: Judy Power's Myeloma StoryApr 19, 2020
Myeloma Crowd Introduces Largest COVID-19 Multiple Myeloma Patient StudyApr 16, 2020
Muscles for Myeloma: Strategies to Avoid Stress EatingApr 06, 2020
Ten Blessings of AdversityMar 22, 2020
El efecto del mieloma múltiple en las relaciones e ideas para mejorarlasMar 12, 2020
XPOVIO (selinexor) Study Shows Impact When Used in Earlier Lines of Multiple Myeloma Therapy with Velcade and DexMar 11, 2020
Why I'm a Myeloma Advocate, by Jenny AhlstromMar 05, 2020
What is a Neutropenic Diet for Multiple Myeloma Patients?Mar 05, 2020
Why all Multiple Myeloma Patients Need a Myeloma SpecialistMar 04, 2020
New CD38 Monoclonal Antibody Sarclisa® (isatuximab) Receives FDA Approval for Relapsed Multiple MyelomaMar 02, 2020
Introducing our New Financial Myeloma Coach, Diahanna ValentineFeb 27, 2020
Myeloma Community Loses Myeloma Great, Dr. Phillip Greipp of the Mayo Clinic RochesterFeb 27, 2020
New Myeloma Combo (carfilzomib/dara/dex) Submitted for FDA ApprovalFeb 13, 2020
New CAR T Therapy Target CD229 Shows Impact in Multiple MyelomaFeb 11, 2020
What's It Like Being a Myeloma Patient? Takeda Oncology Wins App Award.Feb 05, 2020
The Effect of Multiple Myeloma on Relationships and Ideas to Make Things BetterJan 31, 2020
Sanofi and Sebia Develop New Monoclonal Protein Detection Test in Multiple MyelomaJan 27, 2020
How is Active Multiple Myeloma Defined?Jan 24, 2020
Aumento del riesgo de infección en pacientes con MGUSJan 17, 2020